Trio-Tech Intl Analyst Price Targets

Wall Street analyst price targets and consensus rating for Trio-Tech Intl (TRT).

Price Target Range — 1 Quarters

Analyst Consensus — 1 Analysts

1Buy

Consensus RatingBuy# Analysts1Avg. Consensus PT$17Upside to Avg. PT+175.5%

Rating Trend — Last 9 Months

Recent Analyst Actions

모든 평가 보기 →

Date	Firm	Analyst	Action	Rating Change	Price Target
Sep 28, 2026	D. Boral Capital	Patrick McCann	Initiate	Buy	$17

Analyst Ratings News

PRO
D. Boral Capital Initiates Coverage On Trio-Tech Intl with Buy Rating, Announces Price Target of $17

D. Boral Capital analyst Patrick McCann initiates coverage on Trio-Tech Intl (NASDAQ:TRT) with a Buy rating and announces Price Target of $17.

Benzinga Newsdesk

15 Biggest Mid-Day Gainers For Wednesday

Benzinga

18 Biggest Mid-Day Gainers For Monday

Benzinga

Bank of America Raises PO on Auxilium Pharmaceuticals to $24

Benzinga

Bank of America Reviews a Survey on Auxilium Pharmaceutical

Benzinga

Trio-Tech International

뉴스

파트너 / 기고자

벤징가 글로벌

Trio-Tech Intl Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PRO
D. Boral Capital Initiates Coverage On Trio-Tech Intl with Buy Rating, Announces Price Target of $17

15 Biggest Mid-Day Gainers For Wednesday

18 Biggest Mid-Day Gainers For Monday

Bank of America Raises PO on Auxilium Pharmaceuticals to $24

Bank of America Reviews a Survey on Auxilium Pharmaceutical

People Also Watch

People Also Watch

Trio-Tech International

뉴스

파트너 / 기고자

벤징가 글로벌

Trio-Tech Intl Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PROD. Boral Capital Initiates Coverage On Trio-Tech Intl with Buy Rating, Announces Price Target of $17

15 Biggest Mid-Day Gainers For Wednesday

18 Biggest Mid-Day Gainers For Monday

Bank of America Raises PO on Auxilium Pharmaceuticals to $24

Bank of America Reviews a Survey on Auxilium Pharmaceutical

People Also Watch

People Also Watch

PRO
D. Boral Capital Initiates Coverage On Trio-Tech Intl with Buy Rating, Announces Price Target of $17